BioCentury
ARTICLE | Clinical News

Ascenta preclinical data

May 11, 2009 7:00 AM UTC

AT-406 was active as a single agent in several mouse models of cancer, as well as in breast, lung, pancreatic, prostate and bladder cancer cell lines in vitro. Additionally, AT-406 plus combination ty...